[Focus on Achalasia]

Presse Med. 2018 Jan;47(1):11-18. doi: 10.1016/j.lpm.2017.08.010. Epub 2017 Sep 14.
[Article in French]

Abstract

The pathophysiology of achalasia is largely unknown, and involves the destruction of ganglion cell in the esophageal myenteric plexus. High-resolution esophageal manometry is the key investigation. Endoscopic pneumodilatation and laparoscopic Heller myotomy have comparable short-term success rates, around 90%. The main complication after pneumodilatation is esophageal perforation, occurring in about 1% of cases. Peroral endoscopic myotomy is a promising treatment modality, however with frequent post-procedural gastroesophageal reflux.

Publication types

  • Review

MeSH terms

  • Botulinum Toxins, Type A / therapeutic use
  • Calcium Channel Blockers / therapeutic use
  • Diagnosis, Differential
  • Dilatation / methods
  • Esophageal Achalasia* / diagnosis
  • Esophageal Achalasia* / physiopathology
  • Esophageal Achalasia* / surgery
  • Esophageal Achalasia* / therapy
  • Esophageal Perforation / etiology
  • Esophagoscopy / methods
  • Heller Myotomy
  • Humans
  • Manometry / methods
  • Myenteric Plexus / physiopathology
  • Postoperative Complications / etiology
  • Sphincterotomy / methods

Substances

  • Calcium Channel Blockers
  • Botulinum Toxins, Type A